Report an error

Spotted something inaccurate in “CAR-T Therapy Delivers Major Survival Advantage in Relapsed Multiple Myeloma”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.